Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Almeida

Showing results (531-540 of 549) with videos related to

Pageof 55
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritisRaphael Sanches Peres, Foo Y Liew, Jhimmy Talbot, et al.
Critical Care Medicine|February 21, 2025
Acetylsalicylic Acid Treatment in Patients With Sepsis and Septic Shock: A Phase 2, Placebo-Controlled, Randomized Clinical TrialThiago M L Almeida, Flávio G R Freitas, Rodrigo C Figueiredo, et al.
Urologia Internationalis|July 6, 2018
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional StudyMatteo Ferro, Mihai Dorin Vartolomei, Francesco Cantiello, et al.
Endocrine|February 25, 2017
Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male ratsClaudinéia C S Franco, Kelly V Prates, Carina Previate, et al.
Clinical Genitourinary Cancer|August 6, 2018
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder CancerMihai Dorin Vartolomei, Matteo Ferro, Francesco Cantiello, et al.
European Urology Oncology|June 4, 2019
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder CancerFrancesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.
World Journal of Urology|July 12, 2018
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, et al.
Journal of Cancer|December 7, 2018
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder CancerMatteo Ferro, Giuseppe Di Lorenzo, Carlo Buonerba, et al.
World Journal of Urology|April 18, 2019
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorM Ferro, G Di Lorenzo, M D Vartolomei, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 6, 2020
Prevalence and Outcomes of Congenital Heart Disease in Very Low Birth Weight Preterm Infants: An Observational Study From the Brazilian Neonatal Network DatabaseDaniela Anderson, Davi Casale Aragon, Walusa A Gonçalves-Ferri, et al.
Pageof 55

Showing results (531-540 of 549) with videos related to

Sort By:
Pageof 55
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritisRaphael Sanches Peres, Foo Y Liew, Jhimmy Talbot, et al.
Critical Care Medicine|February 21, 2025
Acetylsalicylic Acid Treatment in Patients With Sepsis and Septic Shock: A Phase 2, Placebo-Controlled, Randomized Clinical TrialThiago M L Almeida, Flávio G R Freitas, Rodrigo C Figueiredo, et al.
Urologia Internationalis|July 6, 2018
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional StudyMatteo Ferro, Mihai Dorin Vartolomei, Francesco Cantiello, et al.
Endocrine|February 25, 2017
Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male ratsClaudinéia C S Franco, Kelly V Prates, Carina Previate, et al.
Clinical Genitourinary Cancer|August 6, 2018
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder CancerMihai Dorin Vartolomei, Matteo Ferro, Francesco Cantiello, et al.
European Urology Oncology|June 4, 2019
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder CancerFrancesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.
World Journal of Urology|July 12, 2018
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, et al.
Journal of Cancer|December 7, 2018
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder CancerMatteo Ferro, Giuseppe Di Lorenzo, Carlo Buonerba, et al.
World Journal of Urology|April 18, 2019
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorM Ferro, G Di Lorenzo, M D Vartolomei, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 6, 2020
Prevalence and Outcomes of Congenital Heart Disease in Very Low Birth Weight Preterm Infants: An Observational Study From the Brazilian Neonatal Network DatabaseDaniela Anderson, Davi Casale Aragon, Walusa A Gonçalves-Ferri, et al.
Pageof 55